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 There are approximately 5.7 million Americans currently living with Alzheimer’s 
Disease (AD). Early detection of cognitive impairment allows for earlier treatment, potentially 
slowing or halting cognitive decline. A 30-min web-camera eye tracking assessment (30-min 
VPC) has been validated as a tool to predict AD risk. However, a shorter version would allow for 
greater scalability and improve user experience. The purpose of this study was to: 1) determine 
the validity of the 5-minute web-camera based VPC test with the 30-min test, 2) determine the 
test-retest reliability of the 5-min test, 3) compare the 5-minute test scores of cognitively intact 
adults (18-39 years of age) to the scores of cognitively intact older adults (>65 years of age), 4) 
examine the relationship between the 5-min web camera based VPC test and additional cognitive 
tests. This prospective study included two groups, both with normal cognitive function: 24 young 
adults (26.5 + 7.4 years) and 20 older adults (79.3 + 6.4). Participants were tested on two 
separate occasions. Trial 1 included the Montreal Cognitive Assessment (MoCA), Digit Symbol 
Coding, NIH Toolbox Assessment, 30-min VPC, and 5-min VPC. Trial 2 occurred at least 14 
days later and participants completed the 5-min VPC, Digit Symbol Coding, NIH Toolbox, and 
dual-task walking assessments. The 5-min VPC significantly correlated to the 30-min VPC 
during the first (p = .003) and second (p = .001) trial, and showed significant test re-test 
reliability (p < .001). The 5-min VPC mean scores were 83% and 80% for Trial 1 and Trial 2, 
respectively, with a significant time interaction (p = .04). There was a significant relationship 
between the 5-min VPC and DCCS ( p = .03), MoCA (p = .00), and Digit Symbol Coding (p = 
.00), during Trial 1. As well as Flanker (p < .01), PCPST (p = .00), PSMT (p < .01), MoCA (p = 
.00), and Digit Symbol Coding ( p = .00), during Trial 2. The results from this study suggest the 
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According to the Alzheimer’s Association (2018), Alzheimer’s Disease (AD) is the sixth 
leading cause of death in the United States (US), with approximately 5.7 million Americans 
currently living with AD, of which 5.5 million are 65 years of age or older. From 2000 to 2015, 
the number of deaths due to heart disease decreased by 11%, whereas the deaths from AD 
increased by 123%. This presents the importance of research and education of the general 
population, in an effort to decrease the rate of deaths and ideally decrease prevalence of AD 
altogether. In 2018 alone, AD and other dementias were estimated to cost the US $277 billion 
dollars, with both costs estimated to rise to $1.1 trillion and prevalence estimated to increase to 
14 million, by the year 2050. With early detection and accurate diagnosis, up to $7.9 trillion 
could be saved in medical and care costs. While there is not currently a cure for AD, studies have 
shown various interventions have the ability to slow the progression of the disease (Nelson & 
Tabot, 2015; Nganda et al., 2015; Rosenburg et al., 2017). This means early detection of 
cognitive decline is crucial. 
Cognitive disorders are classified on a spectrum dependent on phenomenological, 
epidemiological, clinical, neuropsychological, and biological variables. Mild Cognitive 
Impairment (MCI) is the first stage of cognitive decline, characterized as memory loss that 
deviates from normal aging (Alistair & Zandig 2002; Zola, Manzanares, Clopton, Lah, & Levey, 
2012). The development of MCI puts the individual at a greater risk of developing dementia, 
which is a diagnosis of a group of symptoms associated with a decline in memory and thinking 
skills, severe enough to interfere with the ability to perform activities of daily living. 
Furthermore, AD is a specific disease, within the diagnosis of dementia, that causes a decline in 





information and affecting mood and behavior (Alzheimer’s Association, 2018). MCI does not 
always progress to dementia and the development of dementia varies tremendously between 
individuals who do convert (Hayat et al., 2014). However, MCI puts individuals at an increased 
risk of developing AD when compared to healthy individuals, with the progression estimated at 
6% to 25% per year (Crutcher et al., 2009).  Furthermore, AD is the most common cause of 
dementia and makes up 60-80% of total dementia cases (Alzheimer’s Association, 2018). 
It is common for changes in memory to go undetected for the first 7-10 years. It is 
important to know the risk of developing dementia and to detect impairments as soon as possible, 
so preventive interventions can be implemented, in an effort to slow the progression of the 
disease. This means effective, highly sensitive memory tests are imperative to detect possible 
deficiencies, as early as possible (Elias et al., 2000). Visual Paired Comparison (VPC) is a 
validated memory recognition test used to compare the amount of time a subject spends viewing 
a new/novel image to an image already seen, when displayed side-by-side. Being able to track 
these eye movements during VPC and use the results as a screening tool for cognitive 
deficiencies, improves the ability to detect early stages of MCI, predict the risk of developing 
MCI/dementia, and track cognitive function over time (Crutcher et al., 2009; Daffner, Scinto, 
Weintraub, Guinessey, & Mesulam, 1992; Lagun, Manzanares, Zola, Buffalo, & Agichtein, 
2011). 
A commercial grade eye tracker, which consists of a high frame rate camera, capable of 
capturing a number of visual features, has been validated to track and record eye movement 
during VPC (Crutcher et al., 2009; Lagun et al., 2011) However, these cameras are expensive, 
which led to the validation of web-cameras as an alternative. Web-cameras are readily available 





and accessible to the public (Y. Lin, R. Lin, Y. Lin, & Lee, 2013). A 30-minute VPC eye 
tracking assessments, using a built-in web-camera, has been validated (Bott et al., 2017). 
However, with the extensive amount of time required for testing, a shorter version of the same 
assessment is needed to increase efficiency and improve the ability to use the test as a screening 
tool. 
Operational Definitions 
Cognition encompasses the processes of the brain involved in the ability to gain 
knowledge and comprehend, which includes thinking, knowing, remembering, judging, and 
problem solving. These functions are used for language, imagination, perception, and the ability 
to plan and execute certain behaviors (National Institutes of Health, 2017). MCI is described as 
the stage between normal cognitive ageing and dementia. There are clear signs of impairment to 
memory when compared to healthy controls, but impairment is less than patients with mild 
dementia. Dementia is a non-specific diagnosis used to describe a group of symptoms, including 
the decline of cognition and other skills that may impair a person’s ability to perform activities of 
daily living. Furthermore, AD is a specific disease within the diagnosis of dementia that causes a 
decline in memory, thinking, and behavior, specifically inhibiting the ability to remember newly 
learned information (Alzheimer’s Association, 2018). VPC task is a method that displays a series 
of two identical images side-by side, which become the familiar images, followed by a series of 
slides with a familiar image displayed next to a new/novel image (Crutcher et al., 2009; Daffner 
et al., 1992). 
Literature Review 
MCI, dementia, and AD are all diagnoses for varying levels of cognitive impairment. 





temporal lobe, impairing recollection. With MCI, often other cognitive abilities are preserved, 
but it does have the potential to develop to dementia. The development of dementia is 
multifactorial, including both genetic and environmental factors. Risk factors may include, but 
are not limited to; age, alcohol abuse, smoking, hypertension, obesity, dyslipidemia, vascular 
damage, and neural damage. However, physical activity, education, and cognitive and social 
activities have shown to protect against the development of dementia. The current method for 
predicting the risk for developing dementia is the CAIDE (Cardiovascular Risk Factors, Aging 
and Dementia) Dementia Risk Score which uses age, education, gender, blood pressure, body 
mass index, total cholesterol, and physical activity. The greater the score, the greater the risk of 
dementia (Kivipelto et al., 2013). 
VPC task recognition aims to detect impairments in memory to predict MCI and AD 
development. In 1992, researchers developed an objective measure to define cognitive 
impairment by using an infrared light camera to track the pupils of participants. Curiosity slides, 
which contain a regular and irregular figure, and incongruous picture slides, a photo containing 
an irregular stimulus, such as a lion sitting at a desk in a classroom of children, were used. AD 
patients spent significantly less time looking at both the irregular figures and the irregular 
portions in the incongruous pictures, when compared to controls who were matched based on 
age, education, and work experience (Daffner et al., 1992). The ability to measure, and track 
cognitive impairment over time, allows interventions to be tested to determine ways to further 
prevent cognitive decline. 
Current VPC methods use familiar and novel images to detect impairment. Participants 
are shown two identical images, side-by-side, during a familiarization period. With varying time 





second delays and two-minute delays between stimuli, Crutcher et al. (2009), compared an MCI 
group to a matched Parkinson’s and cognitively intact control group. Results found there was no 
significant difference between groups during the two-second delay. However, during the two-
minute delay, the MCI group spent approximately 53% of total time viewing the new image, 
whereas the Parkinson’s and cognitively intact groups spent 71% and 74% of their time on the 
new image, respectively. VPC specifically measures the percentage of time spent looking at 
novel images, which target declarative memory. These results suggest VPC task has the potential 
to be used as a screening tool for detecting impairment. Individuals spending less than 65% of 
time looking at the novel image have an increased risk of developing MCI/AD. 
In addition to the infrared eye tracking system, Lagun et al. (2011) validated the use of 
Support Vector Machines (SVM), which is an automatic classification algorithm. SVM accounts 
not only the amount of time spent looking at the novel image verse the familiar image, but also 
the time spent on the “grey area” between images. Most importantly, it detects eye movement 
patterns, specifically fixations, saccades, and re-fixations. Prior techniques for distinguishing 
normal subjects from MCI subjects was 67% accurate, 60% sensitive, and 73% specificity. Using 
SVM performance of accuracy, sensitivity, and specificity increased to 87%, 97%, and 77%, 
respectively. Potentially, this allows for more sensitive detection of MCI and/or the risk of 
developing MCI in participants prior to diagnosis. 
These findings attest to the validity of VPC and its ability to differentiate between control 
individuals, who have normal cognitive function, and individuals with MCI. A three-year 
longitudinal study, using 32 MCI participants and 60 control participants, was used to determine 
the ability of VPC to predict which individuals in the control group and which MCI individuals 





three-year trial, 13 MCI patients developed AD and four control subjects developed MCI, which 
placed them in the converter group (CONV). The remaining participants were placed in the non-
converter group (NONCONV). During the VPC task, the scores associated with the percentage 
of time looking at the novel image was significantly lower in the CONV group compared to the 
NONCONV group, with no significant difference between the CON and MCI participants within 
the CONV group. Additionally, when the same scores were compared to a group of 20 patients 
with AD, there was no significant difference. Furthermore, both the participants with MCI and 
the CON participants in the CONV group had significantly lower VPC mean scores than the 
NONCONV group. Most importantly, out of the 43 subjects with a VPC score ≥ 67, there were 
zero participants who converted. On the contrary, eight of the nine participants with a VPC score 
≤ 50 converted over the three-year span. A receiver-operating characteristic curve using scores 
from all the participants showed an area under the curve of .903, which displays a strong ability 
for VPC to predict the chances of a participant’s diagnosis changing within the next three years 
(Zola et al., 2012). 
With the accuracy, sensitivity, and specificity of VPC increasing using advanced 
technology, Bott et al. (2017), further investigated the idea of administering VPC using a web-
camera, in an effort to make VPC more accessible to the general population. Research eye 
tracking cameras not only require a significant amount of setup and maintenance, but also cost 
up to $50,000. This has confined VPC testing to research labs, making it difficult to test large 
populations. Web-cameras have become standard hardware in smart devices and a readily 
available to the general population, without additional costs. Fifty-four clinically normal older 
adults completed three trials of VPC while simultaneously recording eye tracking using both the 





and the built-in laptop web-camera, scored manually by human coders, collecting three FPS, five 
FPS, and ten FPS. With a strong correlation between all three-manual web-camera scores, the 
three FPS scores were compared to the standard eye tracking score. The results showed a strong 
mean correlation of .76, between the eye tracker camera and the web-camera at three time points. 
The web-camera based tasks were also more reliable with only 2.3% of tasks excluded due to 
technical issues compared to 10% of the eye tracker-based tasks. The manual recording not only 
showed fewer data quality issues, but also showed a strong correlation to the automatic scoring 
methods previously used. With web cameras being easily accessible to the population, this 
allows for VPC to be administered with minimal costs, while still producing valid and reliable 
results. 
There is currently no cure, but with early detection, there are interventions aimed at 
slowing the progression of AD. Dietary interventions, including the Mediterranean diet and the 
Dietary Approaches to Stop Hypertension (DASH), have been shown to produce greater scores 
in the Mini-Mental State Examination and improved psychomotor speed, when compared to 
controls. The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet has 
been developed to treat patients with AD. Results showed that high adherence to the previously 
mentioned diets, along with moderate adherence to the MIND diet, all showed decreased risk of 
AD (Morris et al., 2015). Furthermore, the FINGER multi-domain approach, including diet, 
strength and aerobic training, cognitive, and social interventions over a 24-month period was 
used in a sample of 1,168 older adults, ages 60-77 years, who were at an increased risk for 
developing dementia. Results showed improved executive function, processing speed, memory, 
and neurological test scores, compared to the control who received only regular health advice 





sociodemographic, socioeconomic status, cognition, cardiovascular factors, and cardiovascular 
comorbidity did not have an effect on the outcome of the multi-domain intervention. These 
interventions can be used in conjunction with the web-camera administration of VPC tasks to 
potentially reduce the number of participants who are at a high risk to convert from normal to 
MCI and/or MCI to AD. 
In order to not only slow the progression of dementia, but to prevent cognitive decline 
overall, methods used to detect impairment and measures used to calculate risks for developing 
dementia in the future need to be further developed and perfected. Early detection and prevention 
are imperative to battle a disease that has no cure. 
The purpose of this study was muti-factorial and includes the following: 1) determine the 
validity of the 5-minute web-camera based VPC test with the 30-min test, 2) determine the test-
retest reliability of the 5-min test, 3) compare the 5-minute test scores of cognitively intact adults 
(18-39 years of age) to the scores of cognitively intact older adults (>65 years of age), 4) 




This was a non-experimental, prospective study. This design compared scores both 
within the young adult group (18-39 years of age), and between the young adults and the older 
adults (>60 years of age).  The independent variable was the age group cohort. The dependent 
variables were the 5-min VPC results and the scores of the additional cognitive tests: Montreal 







Demographics. Height was measured, to the nearest 0.5cm, using a standing stadiometer. 
Subjects are asked to remove their shoes and stand up as straight as possible. Weight was 
measured, to the nearest 0.5kg, using a balance-beam scale. Subjects were asked to remove their 
shoes and heavy clothing (sweaters/jackets/coats) and empty their pockets. Body composition 
was measured using a dual-energy x-ray absorptiometry (DXA). 
MoCA. The Montreal Cognitive Assessment (MoCA) is a paper-pencil test used to 
screen for cognitive impairment and assesses multiple cognitive domains. These cognitive 
domains include attention and concentration, executive functions, memory, language, 
visuoconstructional skills, conceptual thinking, calculations, and orientation. The test takes 
approximately 10 minutes, with a possible 30 points. If a score > 26 was obtained, the participant 
was categorized as cognitively normal and completed the other assessments. With a score < 26 or 
diagnosed with AD, the participant was categorized as cognitively impaired. For these 
individuals, the signature of a guardian was required in order to complete the remaining tests. 
The ability of the MoCA to identify MCI and dementia has been shown to be 84-90% and 94-
100% effective, respectively (Nasreddine et al., 2005; Smith, Gildeh, & Holmes, 2007). 
Digit Symbol Coding Test. The Digit Symbol Coding Test is a paper-pencil test used to 
assess cognition, specifically processing speed and executive functioning. Rows of blank squares 
were matched with randomly assigned numbers from one to nine. Above the rows was a 
reference key that pairs each number with a different symbol. The reference key was used to pair 
as many symbols as possible with the assigned number, within 90 seconds. Digit Symbol Coding 
was found to be the best test for screening cognitive impairment, when compared to various 





NIH Toolbox. NIH developed an application with a standard set of validated, reliable 
tests used to assess neurological and behavioral function. The following tests are within the 
cognitive domain of the NIH Toolbox: Flanker Inhibitory Control and Attention, Dimensional 
Change Card Sort (DCCS), Pattern Comparison Processing Speed, Picture Sequence Memory. 
The tests were administered using an iPad, with the order of test administration to always follow 
the order listed above. Prior to the test trials, it was demonstrated how to complete each task, in 
addition to a given number of practice sets. If the participant answered at least three out of four 
correctly during the practice set, the test began. If less than three were correctly answered, two 
additional practice sets were given. However, the test ended if three answers were not correct by 
the end of the third practice set (NIH, 2017). When compared to the Gold Standard tests, the NIH 
Toolbox has been shown to be a valid and reliable assessment, for adults, of six domains of 
cognition: working memory, executive function, episodic memory, processing speed, language 
and reading. Each assessment within the NIH toolbox is strongly related to the domain intended, 
while also being weakly related to the other domains, which attests to the validity of the toolbox, 
in its entirety. There were no differences found, when compared to gold standard measures, 
across 20-85 year age groups, allowing for reliable and consistent testing over the course of a 
lifetime (Mungas et al., 2014). 
Flanker Inhibitory Control and Attention Test. The participant was instructed to focus 
on a particular stimulus while inhibiting attention to the stimuli flanking it. A row of arrows was 
presented on the screen. Sometimes the arrows were pointing in the same direction and 
sometimes the arrows were pointing in different directions. The objective was to select the 
button that matches the way the middle arrow was pointing. This was a method used to measure 





Dimension Change Card Sort Test (DCCS). This is a cognitive test used to measure 
flexibility and attention. Two target pictures were presented that vary along two dimensions (ex., 
shape and color). Participants were asked to match a series of bivalent test pictures (ex., yellow 
balls and blue trucks) to the target pictures, first according to one dimension (ex., color) and after 
numerous trials, according to the other dimension (ex., shape). Instruction on how to match 
pictures according to shape were given along with the necessary practice trials. Next, it was 
explained how to match the pictures according to color, again followed by the practice items. 
The 30-test items are a combination of both matching color and shape dependent on what was 
indicated in the middle of the screen (NIH, 2017). 
Pattern Comparison Processing Speed Test (PCPST). In order to assess processing 
speed, two pictures were presented on the screen side-by-side. If the pictures were identical, the 
participants selected the “yes” button and if the pictures were not identical, the participant 
selected the “no” button. Six practice items were given before the test begins. With a total of 130 
items, the test was completed when all 130 items appear or after 85 seconds have elapsed (NIH, 
2017). 
Picture Sequence Memory Test (PSMT).  Sequences of pictured objects and activities 
were presented in a specific order to test episodic memory. The objective was to reproduce the 
pictures in the same order they appeared on the screen. It was demonstrated how to drag the 
picture on the screen prior to the four-step practice sequence. The test consisted of two trials. The 
first trial was a 15-step sequence and the second trial was an 18-step sequence, which included 
all 15 pictures from the first trial (NIH, 2017). 
Visual Processing Comparison (VPC). The VPC tests (Neurotrack’s 30-min and 5-min 





the videos of the participants’ face were stored so their eye movements can be tracked. The 5-
min VPC test is a condensed version of the 30-minute test. Additionally, the 5-min test is active 
because it instructs the participant to look at the new image they have not yet seen, whereas the 
30-min test is passive and does not instruct the participant what to do while looking at the images 
(NIH, 2017). The videos of the participants’ faces were analyzed by Neurotrack technicians.  
Dual-task. Cognitive function and the ability to walk are related, meaning cognitive 
impairment has an effect on gait ability, which can be measured using dual-task assessments. 
Dual-task has shown to be reliable (r ≥ .75) when testing individuals with Parkinson’s disease, 
MCI, dementia, AD, and multiple sclerosis (Yang et al., 2017). Dual-task assessment measures 
the time it takes to walk 10-meters under various instructions. The first measure was walking at a 
normal pace. The second was walking at a fast pace, without jogging. Two trials at each pace 
were completed, timed, and recorded. The next measure was at walking at a normal/habitual 
pace while counting down by threes from a random number assigned to them. The final was the 
same dual-task but at the maximal walking pace. Different random numbers were assigned to 
each of the four dual-task trials. Individuals with cognitive impairment had more difficulty 
completing the dual-task trials compared to healthy adults, which resulted in increased time to 
walk 10-meters (Doi et al., 2014). 
Procedures 
Once IRB approval was obtained, adults (18-39 years) and older adults (>60 years) with 
normal cognitive function, were recruited. A total of 44 participants were used to complete the 
study (24 young adults and 20 older adults). The young adults reported to the Exercise Science 
Research Center at the University of Arkansas for two separate trials. The older adults completed 





completed the informed consent document, the medical history questionnaire, and the MoCA, to 
screen for cognitive impairment, prior to the administration of the cognitive assessments (Digit 
Symbol Coding Test and NIH Toolbox) and the 30-min and 5-min VPC tests. 
The order of the cognitive tests remained the same for all trials. However, the participants 
were randomly assigned to determine the order of test administration for the cognitive tests and 
the VPC tests. During the first trial, if the participant completed the cognitive assessments before 
the VPC tests, they were administered the VPC test before the cognitive assessments during the 
second trial, and vice versa. 
The second trial occurred at least 14 days after the first trial. During the session subjects 
repeated the cognitive tests (Digit Symbol Coding Test and the NIH Toolbox) and the 5-min 
VPC test. Additionally, dual-task measures and demographics (height, weight, and body 
composition) were taken during the second trial. 
Data Analysis 
To determine the validity of the 5-min test compared to the 30-min VPC and the other 
cognitive assessments, a Pearson correlation was used. To determine the test-retest reliability of 
the 5-min VPC test, a paired t-test using the day 1 and day 14 data was completed. Additionally, 
a repeated measure ANOVA was used to determine differences that may exist between age 
groups. Statistical significance was set at α = .05. Demographic information was presented as 
means ± SD. 
Results 
Participants Characteristics 
 A total of 44 adults completed the study. This included 24 young adults (26.5 + 7.4 years) 





75% of participants were college or trade school graduates. Not all web-camera VPC data were 
able to be scored due to technical difficulties, which included poor recording quality or network 
connectivity, glare from glasses, and/or low light in the testing room. Of the 44 participants who 
completed the assessment, 98% of the 30-min VPC scores were evaluated, 100% of Trial 1 and 
88.5% of the Trial 2 of the 5-min VPC tests were analyzed. On average, the second trial session 
took place 22.4 days after the first. Table 1 displays the characteristics of the study cohort. 
Table 1 
Characteristics of the study cohort (n = 44). 
  Young Adults  Older Adults Significance 
(p) 
N 24 20  
Average age (years) 26.5 ± 7.4 79.3 ± 6.4 p < .001 
Sex p = .87 
N Female (%) 15 (62.5%) 13 (65.0%)  
Education  p = .08 
High School Graduate 4.2% 5.0%  
Some College 29.2% 10.0%  
College Graduates or 
higher  
66.7% 85%  
Race p = .21 
European-American 83.3% 95.0%  
Other 16.7% 5.0%  
Biometric 
Height (cm) 170.1 ± 8.6 166.5 ± 8.6 p = .38 
Weight (kg) 74.5 ± 17.8 73.2 kg ± 14.3 p = .96 






Relationship between the 30-min VPC and 5-min VPC Tests 
Among the young adults, analysis displayed a significant positive relationship between 
the 30-min VPC and 5-min VPC tests. The 30-min VPC was significantly correlated with the 5-
min VPC during the first (r = .601; p = .003) and second (r = .722; p = .001) trials. This shows 
the validity of the 5-min VPC test and its ability to measure declarative memory.  
Reliability of the 5-min VPC Test 
 The results of Trial 1 were positively correlated to the Trial 2 results for the 5-min VPC 
test (r = .81; p = .00). This shows the reliability of the assessment. Furthermore, there was no 
significant difference between Trial 1 and 2 for the 5-min VPC test (p = .80). Mean scores for 
Trial 1 and 2 were .812 and .808, respectively.  
Comparing 5-min VPC Test Scores Between Young and Older Adults 
 Repeated measures ANOVA revealed no change over time between young and older 
subjects for the 5-min VPC assessment (F = 3.16, p = .08; Figure 1). Mean VPC values were 
83% (young adults, 81%; older adults, 85%) and 80% (young adults, 81%; older adults, 80%) for 
Trials 1 and 2, respectively (Figure 2). 
 







Figure 2. The mean values of the 5-min VPC, Trial 1 and 2, for the young and older adults.  
Associations Between the 5-min VPC Test and Other Cognitive Assessments 
Using cognitive function as a specific domain, the correlation between the 5-min VPC 
test and the NIH Toolbox assessments was examined. The age-based normative percentile scores 
were used to compare each task to the performance of the 5-min VPC test. During Trial 1 (Table 
2), there was a significant relationship between the 5-min VPC and DCCS (r = .31; p = .03), 
MoCA (r = .50, p = .00), and Digit Symbol Coding (r = .47, p = .00), but not the Flanker (r = 
.14, p = .33), PCPST (r = .22, p = .14) or PSMT (r = -.09, p = .55). During Trial 2 (Table 3), 
significant correlations were found between the 5-min VPC test and Flanker (r = .38, p < .01), 
PCPST (r = .52, p = .00), PSMT (r = .49, p < .01), MoCA (r = .65, p = .00), and Digit Symbol 
Coding (r = .57, p = .00), but not DCCS (r = .23, p = .12), dual-task habitual speed (r = -.24, p = 






Table 2.  
Correlations between 5-min VPC test data from Trial 1 and cognitive assessments from Trial 1. 
  VPC-5 VPC-30 Flanker DCCS PCPST PSMT MoCA DSC 
VPC-5 -               
VPC-30 .55** -             
Flanker .14 -.09 -           
DCCS .31* .00 .62** -         
PCPST .21 .20 .61** .52** -       
PSMT .09 .13 .32* .28* .35* -     
MoCA .50** .26 .47** .27* .57** .39** -   
DSC  .47** .35** .45** .47** .43** .58** .51** - 
Note. *p < .05; ** p < .01; Flanker = Flanker Inhibitory Control Test, DCCS = Dimension 
Change Card Sort Test, PCPST = Pattern Comparison Processing Speed Test, PSMT = Picture 









Correlations between 5-min VPC test data from Trial 2 data and cognitive assessments from 
Trial 2. 
  VPC-5 VPC-30 Flanker DCCS PCPST PSMT MoCA DSC DT-HS DT-MS 
VPC-5 -                   
VPC-30 .49**  -                 
Flanker .38** .09 -               
DCCS .23 .03 .60** -             
PCPST .52** .17 .56** .57** -           
PSMT .49** .27 .09 .25 .33* -         
MoCA .65** .26 .39** .35* .58** .51** -       
DSC .57** .31* .54** .40** .68** .43** .57** -     




-   
DT-MS .02 .11 -.20 -.18 -.19 .09 -.02 -.02 .13 - 
Note. *p < .05; ** p < .01; Flanker = Flanker Inhibitory Control Test, DCCS = Dimension 
Change Card Sort Test, PCPST = Pattern Comparison Processing Speed Test, PSMT = 
Picture Sequence Memory Test, MoCA = Montreal Cognitive Assessment, DSC =Digit 
Symbol Code Test, DT-HS = Dual-task Habitual, DT-MS = Dual-task maximal speed 
 
Discussion 
  The four primary objectives of this study were to: 1) validate the 5-minute web-camera 





test, 3) compare the 5-min VPC test scores of the young adults (18-39 years of age) to the scores 
of the older adults (>60 years of age), and 4) examine the relationship between the 5-min VPC 
test and additional cognitive assessments. Among young adults, the results showed adequate 
validity between the 5-min VPC and 30-min VPC test. The 5-min VPC scores were also 
significantly correlated between trials, with no significant differences between Trial 1 and Trial 
2. Not only is the 5-min VPC test shorter, but it is an active test (i.e. participants are instructed to 
look at the new image), which differs from the passivity of the 30-min VPC test. This is 
important because the 5-min VPC is intended to be taken repeatedly over time, rather than solely 
being used as a baseline measure. This eliminates the need to conceal what the test is measuring 
from the participant. Furthermore, the duration of the 5-min VPC lessens the stress on the 
participant and increases the practicality of test administration. 
There was a significant time effect, between trial scores for the 5-min VPC test. 
However, the differences between the groups over time was not significant. This means the 
changes in scores, from Trial 1 to Trial 2, did not differ between age groups. Statistically, the 
group by time interaction is not significant, but amongst the older adults specifically, the 
interaction is trending toward significance.  
The 5-min VPC showed to be significantly related to standard cognitive assessments, 
which suggests the 5-min VPC may be used as a convenient alternative to the longer cognitive 
assessments. This supports the results of previous research which has shown a strong relationship 
between VPC and other cognitive assessments among the older adult population, supporting the 
specific ability of VPC tests to assess processing speed (PCPST), visual episodic memory 
(PSMT), and executive function (Digit Symbol Coding) (Bott et al., 2018). Additionally, 





shown to potentially cause issues with internal validity (Goldberg, Harvey, Wesnes, Snyder, & 
Schneider, 2015). This is the case when administering NIH Toolbox assessments and Digit 
Symbol Coding multiple times, due to the availability of only one version of each assessment 
(Heaton et al., 2014). The minimum of 14 days between trials aims to alleviate the learning 
effect. The learning effect in the 5-min VPC was reduced by the use of alternate forms of the test 
during Trial 1 and 2. 
         The issue of data quality of the VPC tests serves as a limitation of this study. A total of 
six VPC tests were not able to be scored due to glare from glasses, poor lighting in the testing 
room, and/or electronic errors. The tests that were excluded were: the 30-min VPC of one young 
adult and the 5-min VPC trial 2 assessments of five young adults. The subjects completed both 
visits at the testing center, so they were still included in the overall analyses. The assessments 
were completed in a research setting, to ensure high quality data collection, limiting the 
ecological validity of the results. This study included only individuals with normal cognitive 
function. Further research including individuals with cognitive impairment, as well as the 
investigation of varying levels within individuals with cognitive impairment, is needed to further 
validate VPC and its ability to assess cognition among all populations. Additionally, a 
longitudinal study tracking participants overtime, exclusively utilizing the 5-min VPC test, 
would verify the ability of VPC administration in clinical settings, to track cognition throughout 
a lifetime. 
Threats to Validity 
The results of the cognitive tests were based off the participants willingness to complete 
the tests to the best of their abilities. If this was not done, it is a possible threat to the internal 





manual analysis of VPC eye tracking ensured greater accuracy.  The recruitment for the young 
adults was done through the university, meaning it is possible a large sum of participants were 
educated, either pursuing a bachelor's or graduate degree. This may have affected the overall 
scores for the cognitive tests, which does not represent the general population. This affected the 
comparison of the 5-min VPC scores to the cognitive test scores. However, this did not affect the 
results of the test-retest reliability and the validity of the VPC results. 
Assumptions 
It is assumed the participants completed all cognitive tests as quickly as possible and to 
the best of their ability. Furthermore, the participants were expected to pay attention throughout 
the entirety of the VPC tests. It is also assumed participants did not suffer from cognitive 
impairments, which was screened for using the medical history questionnaire and MoCA. 
Limitations 
The 30-min VPC test was only administered during the first trial. Even though a 
crossover design was used, it is possible mental fatigue may have affected the scores of the 
participants who were required to complete the NIH cognitive assessments after the 30-min test. 
Delimitations 
The following are delimitations of the current study. A total of 44 subjects participated in 
the study. Cognitive assessments were completed using both paper-pencil tests and the NIH 
toolbox on an iPad. Subjects were tested in the Exercise Science Research Center at the 
University of Arkansas, or at Butterfield Trail Village. The trials were administered at least 14 








 Among the young adults, the 5-min VPC test demonstrated a moderate convergent 
validity to the 30-min VPC, along with strong test-retest reliability. Between groups, there was a 
significant time interaction, with group by time effect trending in significance. The significant 
relationships between the 5-min VPC and the other cognitive assessments verifies previous 
research, specifically supporting its ability to assess processing speed, visual episodic memory, 
and executive function (Bott et al., 2018). Furthermore, the cohort included both older and young 
adults, generalizing the results to a greater population. 
The scalability of the 5-min VPC test may be greater than other cognitive assessments 
due to its short duration, lessened strain on participants, and convenience of digital delivery. 
Unlike other cognitive assessments, test administration by a trained professional is not needed 
(Heaton et al., 2014). The 5-min VPC test can be completed anywhere with an internet 
connection and web-camera, with minimal instructions required (Bott et al., 2018). This is not a 
diagnostic test for cognitive impairment, but rather a screening tool used as a baseline and way to 
monitor cognition over time in healthy individuals. The efficacy of testing individuals with 
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